Skip to main content

The question facing each investor is how quickly they will need to dump equities as financial conditions tighten.Getty Images/iStockphoto

Our roundup of Canadian small-caps making news and on the move today. This post will be updated through the morning.

Dream Office Real Estate Investment Trust said the final quarter of 2014 was its best with regards to leasing volumes, and that it renewed almost 60 per cent of the leases that expired during this period.

"Overall, we believe the tone of the press release is constructive, and it should have a modestly positive impact on near-term unit price performance," commented Desjardins analyst Michael Markidis. "In addition, management has made a strong statement with respect to future activity, suggesting that it is prepared to spend another $150-million (Canadian) over the next six months."

He left his price target for the REIT at $30 (Canadian) and maintained a "hold" rating.

-

Essential Energy Services Ltd. said its capital budget for 2015 will be $21-million, divided into $13-million of growth capital and $8-million in maintenance. For full-year 2014, the company expects capital expenditures to have totalled $46-million. "In light of expectations for an industry slowdown in 2015, we have set a conservative capital budget," said president and chief executive officer Garnet Amundson. "Despite relatively low capital spending in 2015, with the recent equipment additions and equipment expected in 2015, we will experience significant growth in our fleet of masted coil tubing rigs that are suitable for completion and production work on some of the industry's longest horizontal wells."

Shares are up 11 per cent in early TSX trading.

-

Paladin Energy Ltd. said the liner in the plant run-off tank at its Kayelekera mine in Malawi ruptured during a storm on the night of Jan. 5, which may have resulted in some fluids leaking beyond containment areas. Earlier that day, management had dismissed claims that waste materials from this mine were entering into the local river system as being "sourced from local non-government organisations (NGOs) and individuals openly hostile to the company."

-

SouthGobi Resources Ltd. said that the money laundering charges three of its former employees had been facing in Mongolia have been dismissed, and a related tax investigation case has been transferred back to the court. "We welcome the decision to dismiss the accusations of money laundering," said president and chief executive officer Enkh-Amgalan Sengee. "We will continue to cooperate as required with the relevant authorities concerning the case of alleged violations of Mongolian tax law which has been brought back to court." The company deems the accusations that it violated Mongolian tax law to be "unfounded."

-

Dorel Industries Inc. said it has purchased the assets of Santiago-based bicycle retailer Intercycles. Financial terms of the transaction were not disclosed. Intercycles' locations will be operated by Dorel Sports Chile, a new division tasked with overseeing sales, marketing, distribution and customer service of the company's products in Chile and Peru.

-

GuestLogix Inc. said agreement with Momentum Services, a European catering company, has been expanded and renewed for six years. "As we advance our relationship, Momentum will implement additional solution components, including our next-generation retail solution for use with the Apple iPad and our business intelligence platform, to improve its ancillary revenue potential and heighten crew efficiency while continuing to benefit from secure payment processing and fraud protection," said GuestLogix president and chief executive officer Brett Proud. "This announcement represents our second smartphone and tablet POS technology agreement with a rail customer in the past year, and based on the interest we've been receiving from our customers and the passenger travel industry at large, this is only the beginning."

-

Cipher Pharmaceuticals Inc. said it has licensed the Canadian rights to Ozenoxacin, a topical treatment for impetigo, from Ferrer, a Spanish pharmaceutical company. Financial terms of the deal, which will see Ferrer receive an upfront payment and additional funds as milestones are reached, were not disclosed.

-

More to come.